Catalyst Capital Advisors LLC Glaukos Corp Transaction History

Catalyst Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$54.18 - $65.64 $5,743 - $6,957	-106 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$58.58 - $83.91 $2,401 - $3,440	41 Added 63.08%	106 $7,000
Q2 2019 Aug 08, 2019	BUY	$63.59 - $78.71 $826 - $1,023	13 Added 25.0%	65 $5,000
Q4 2018 Feb 07, 2019	BUY	$52.18 - $67.93 $2,713 - $3,532	52 New	52 $3,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.14B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.